|
|
A Randomised Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS or Low Blast AML: GFM's "Pick a Winner" Trial, with the Impact of Somatic Mutations
Lionel Adès
,
Nicolas Duployez
,
Agnes Guerci-Bresler
,
Kamel Laribi
,
Pierre Peterlin
,
et al.
Article dans une revue
hal-03740498v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Triage Scoring System Based on Early Post-Transplant Complications for Patients with Myelodysplastic Syndrome Requiring ICU after Allo-HCT: An SFGM-TC Study
Federico Garnier
,
Alain Duhamel
,
Ibrahim Yakoub-Agha
,
Alexis Caulier
,
Elodie Drumez
,
et al.
Article dans une revue
hal-03605967v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Aplastic Anemia in the Elderly: A Nationwide Survey on Behalf of the French Reference Center for Aplastic Anemia
Adrien Contejean
,
Matthieu Resche-Rigon
,
Jerome Tamburini
,
Marion Alcantara
,
Fabrice Jardin
,
et al.
Article dans une revue
hal-03606396v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria
Jerome Paillassa
,
Roberta Di Blasi
,
Sylvie Chevret
,
Sophie Bernard
,
Michael Darmon
,
et al.
Article dans une revue
hal-03605011v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|